论文部分内容阅读
目的 :观察依那普利和前列腺素E1 联合用于治疗乙肝炎肝硬化腹水效果。方法 :两组乙型肝炎肝硬化腹水患者 ,A组33例常规综合治疗 ,B组31例在A组治疗基础上应用依那普利和前列腺素E1。观察肝功能 (ALT、TB、A、PTA )和腹水消退效果 ,两组结果对比进行统计学处理。结果 :伊那普利联合前列腺素E1 组肝功能改善后果好于A组 (P<0 05) ,腹水消退情况也好于A组 (x2=8 21 ,P<0 01)。结论 :伊那普利联合前列腺素E1 用于肝炎肝硬化腹水 ,可改善肝功能 ,促进腹水消退 ,有一定预防肝肾综合征发生的作用 ,且副反应小 ,经济适用
Objective: To observe the effect of enalapril and prostaglandin E1 in the treatment of ascites caused by hepatitis B cirrhosis. Methods: Two patients with hepatitis B cirrhosis and ascites were randomly divided into group A (n = 33) and group B (n = 31). Enalapril and prostaglandin E1 were used on the basis of group A treatment. Observed liver function (ALT, TB, A, PTA) and ascites subsided effect, the two groups were compared statistically. Results: The effect of improving the liver function of the enalapril combined with prostaglandin E1 group was better than that of the A group (P <0.05). The regression of ascites was also better than that of the A group (x2 = 821, P <0.01). Conclusions: It is a combination of prostaglandin E1 and hepatic cirrhosis ascites, which can improve liver function, promote the regression of ascites, and prevent the occurrence of hepatorenal syndrome, with less side effects and economical application